King‐Ahmad, Amanda
19  results:
Search for persons X
?
1

Mechanistic Determinants of Daprodustat Drug–Drug Interacti..:

Bi, Yi‐An ; Jordan, Samantha ; King‐Ahmad, Amanda..
Clinical Pharmacology & Therapeutics.  115 (2024)  6 - p. 1336-1345 , 2024
 
?
2

Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vi..:

Tess, David A. ; Kimoto, Emi ; King‐Ahmad, Amanda...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 605-614 , 2022
 
?
3

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Health..:

Mori, Daiki ; Kimoto, Emi ; Rago, Brian...
Clinical Pharmacology & Therapeutics.  107 (2020)  4 - p. 1004-1013 , 2020
 
?
5

Liver‐Targeted Small‐Molecule Inhibitors of Proprotein Conv..:

McClure, Kim F. ; Piotrowski, David W. ; Petersen, Donna...
Angewandte Chemie International Edition.  56 (2017)  51 - p. 16218-16222 , 2017
 
?
7

Utilization of Rosuvastatin and Endogenous Biomarkers in Ev..:

Huh, Yeamin ; Plotka, Anna ; Wei, Hua...
Pharmaceutical Research.  40 (2023)  11 - p. 2639-2651 , 2023
 
?
 
?
 
?
11

P231 - Study to assess the food effect on plasma levels of ..:

King-Ahmad, Amanda ; Rago, Brian ; Luo, Lina..
Drug Metabolism and Pharmacokinetics.  35 (2020)  1 - p. S92 , 2020
 
?
12

Efficient Liver Targeting by Polyvalent Display of a Compac..:

Sanhueza, Carlos A. ; Baksh, Michael M. ; Thuma, Benjamin...
Journal of the American Chemical Society.  139 (2017)  9 - p. 3528-3536 , 2017
 
?
13

In Vitro – In Vivo Extrapolation of Intestinal Availability..:

Trapa, Patrick E. ; Beaumont, Kevin ; Atkinson, Karen...
Journal of Pharmaceutical Sciences.  106 (2017)  3 - p. 898-905 , 2017
 
?
15

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Health..:

Mori, Daiki ; Kimoto, Emi ; Rago, Brian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158214/.  , 2020
 
1-15